Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

In the regulated pharmaceutical sector, maintaining awareness and connectivity is vital. Industry professionals attend ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.

Real Chemistry unveiled its new advisory practice, focused on corporate communications and reputation, in advance of the ...

While the Trump administration remains unpredictable, some pharma experts are optimistic that the regulatory landscape will ...

EMA approval decision for obicetrapib and obicetrapib/ezetimibe fixed dose combo expected in 2H26 ---- Phase 3 PREVAIL CVOT overall event rate ...

What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most viewed breaking news stories on our site for 2025.

By the end of March, the agency could approve multiple “national priority” voucher winners, as well as a gene therapy it ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate, ...

Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...